Argitalpenak (90) JUAN SAINZ PÉREZ argitalpenak

2024

  1. Metabolomics signature as a survival predictor in patients with resectable colorectal liver metastasis

    Clinical and Translational Medicine, Vol. 14, Núm. 1

  2. Modulating anti-inflammatory and anticancer properties by designing a family of metal-complexes based on 5-nitropicolinic acid

    Dalton Transactions, Vol. 53, Núm. 21, pp. 8988-9000

  3. Polymorphisms within autophagy-related genes as susceptibility biomarkers for pancreatic cancer: A meta-analysis of three large European cohorts and functional characterization

    International Journal of Cancer

  4. Principal Bioactive Properties of Oleanolic Acid, Its Derivatives, and Analogues

    Molecules, Vol. 29, Núm. 14

  5. Principal Bioactive Properties of Oleanolic Acid, Its Derivatives, and Analogues

    Molecules, Vol. 29, Núm. 14, pp. 3291

2023

  1. A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk

    International Journal of Cancer, Vol. 152, Núm. 2, pp. 239-248

  2. Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?

    International Journal of Molecular Sciences, Vol. 24, Núm. 9, pp. 8005

  3. Evaluation of Anticancer and Anti-Inflammatory Activities of Some Synthetic Rearranged Abietanes

    International Journal of Molecular Sciences, Vol. 24, Núm. 17

  4. GWAS-Identified Variants for Obesity Do Not Influence the Risk of Developing Multiple Myeloma: A Population-Based Study and Meta-Analysis

    International Journal of Molecular Sciences, Vol. 24, Núm. 7

  5. Identification of novel genetic loci for risk of multiple myeloma by functional annotation

    Leukemia

  6. Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization

    International Journal of Molecular Sciences, Vol. 24, Núm. 10

  7. The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years’ experience of association studies to understand the genetic architecture of pancreatic cancer

    Critical Reviews in Oncology/Hematology, Vol. 186, pp. 104020

2022

  1. A polygenic risk score for multiple myeloma risk prediction

    European Journal of Human Genetics, Vol. 30, Núm. 4, pp. 474-479

  2. Autophagy in Hematological Malignancies

    Cancers, Vol. 14, Núm. 20

  3. Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Vol. 31, Núm. 9, pp. 1863-1866

  4. Evaluation of four prognostic indices in follicular lymphoma treated in first line with immunochemotherapy

    Blood Advances

  5. Type 2 Diabetes-Related Variants Influence the Risk of Developing Prostate Cancer: A Population-Based Case-Control Study and Meta-Analysis

    Cancers, Vol. 14, Núm. 10

  6. Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study

    Blood Cancer Journal

2021

  1. Common gene variants within 3′-untranslated regions as modulators of multiple myeloma risk and survival

    International Journal of Cancer, Vol. 148, Núm. 8, pp. 1887-1894

  2. Do myeloproliferative neoplasms and multiple myeloma share the same genetic susceptibility loci?

    International Journal of Cancer, Vol. 148, Núm. 7, pp. 1616-1624